2 not yet recruiting, 1 completed, 1 enrolling by invitation, 1 unknown. 2 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Attention Deficit Disorder (ADD): new trials by email Literature Review of Attention Deficit Disorder (ADD) trials Research Report on Attention Deficit Disorder (ADD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Quick and Reliable Eye Movement Test to Help Diagnose ADHD in Children. Attention Deficit Disorder With Hyperactivity (ADHD), Attention Deficit Disorder (ADD) | Not yet recruiting | Onovis Augenpraxis | 100 | 2025-09-01 | 2025-08-22 | |
| The Primary Objective of This Study is to Determine Whether Positively Framed Information (PFI) on Side Effects, Compared to Negatively Framed and Extensive Information (NFI) Can Reduce the Number and Severity of Reported Adverse Events Caused by ADHD Medication in Children Aged 7 to 17 Years. Communication Strategy for Side Effect Counseling in ADHD Treatment - Attention Deficit Disorder, Attention Deficit Disorder (ADD) | Not applicable | Not yet recruiting | St. Antonius Hospital | 130 | 2025-01-25 | 2025-01-28 |
| An Investigational Study Examining the Efficacy of QbMobile in Treatment Monitoring in Individuals With ADHD observational study - Attention Deficit Disorder With Hyperactivity (ADHD), Attention Deficit Disorder (ADD) | Enrolling by invitation | Qbtech AB | 175 | 2025-01-15 | 2026-05-06 | |
| Home-Based tDCS in Children With ADHD: A Randomized, Sham-Controlled tDCS and fNIRS Study Home-based transcranial direct current (tDCS) device - Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit Disorder (ADD) | Not applicable | Unknown | Onze Lieve Vrouw Hospital | 75 | 2020-11-05 | 2020-11-18 |
| Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD Strattera, Placebo - Fetal Alcohol Syndrome, Attention Deficit Disorder With Hyperactivity (ADHD) | Phase 1 | Completed | University of Oklahoma | 38 | 2005-08-01 | 2017-04-10 |
Attention Deficit Disorder with Hyperactivity (5) · Drug-Related Side Effects and Adverse Reactions (1) · Fetal Alcohol Spectrum Disorders (1) · Medication Adherence (1) · Neurodevelopmental Disorders (1) · Patient Compliance (1) · Spasm (1)
Attention Deficit and Disruptive Behavior Disorders (5) · Mental Disorders (5) · Neurodevelopmental Disorders (4) · Chemically-Induced Disorders (2) · Alcohol-Induced Disorders (1) · Alcohol-Related Disorders (1) · Behavior (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Fetal Diseases (1) · Health Behavior (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Neuromuscular Manifestations (1) · Pathological Conditions, Signs and Symptoms (1)
Atomoxetine Hydrochloride (1) · Observation (1) · Transcranial Direct Current Stimulation (1)
Onovis Augenpraxis (1) · Onze Lieve Vrouw Hospital (1) · Qbtech AB (1) · St. Antonius Hospital (1) · University of Oklahoma (1)
United States (2) · Belgium (1) · Switzerland (1)
Arine Vlieger, MD, PhD (1) · Choi Deblieck, PhD (1) · Laura J McGuinn, PhD (1) · Liesbet Devalkeneer, MD (1)